The statement that greater doses would not have greater efficacy than the current dose being tested was something we all made much at the time, because that was about as clear a hint as you can get that Kevetrin WORKS. With all the crap that has been going on, I don't remember where that was stated.

Logic exercise: If a bigger dose doesn't seem to have greater efficacy, so you want to continue to the next phase of testing, clearly there IS efficacy, because you wouldn't be continuing with tests if it didn't. And if it seemed to have just SOME efficacy but not enough, you'd want to continue trying bigger doses. But they don't see the need for bigger doses.

Therefore Kevetrin has been shown to be efficacious in the treatment of certain cancers.

QED